The evolving landscape of the economics of HIV treatment and prevention

Bohdan Nosyk; Julio S G Montaner

doi:10.1371/journal.pmed.1001174

The evolving landscape of the economics of HIV treatment and prevention

PLoS Med. 2012 Feb;9(2):e1001174. doi: 10.1371/journal.pmed.1001174. Epub 2012 Feb 14.

Authors

Bohdan Nosyk¹, Julio S G Montaner

Affiliation

¹ British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.

Abstract

Bohdan Nosyk and Julio Montaner argue that the cost-effectiveness of HAART roll out has been significantly underestimated because economic analyses haven't yet taken into account the beneficial impact of HAART on HIV transmission.

MeSH terms

Antiretroviral Therapy, Highly Active / economics*
Cost-Benefit Analysis
HIV Infections / drug therapy
HIV Infections / economics*
HIV Infections / prevention & control
Humans

Grants and funding

DP1 DA026182/DA/NIDA NIH HHS/United States